Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
about
Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyMultifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesNeoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasisThe effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cellsChitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineRole of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activityImmunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.Clostridium sporogenes delivers interleukin-12 to hypoxic tumours, producing antitumour activity without significant toxicity.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.
P2860
Q28084489-A35342E5-261C-4F02-A682-02DEDE6AE399Q33612179-B3914CFF-505B-420F-993F-05B67B949C7AQ34356322-CF556F0F-6F7C-4F35-A4D6-62E580E7272FQ35157433-6B0B9AB0-4ECA-40E2-96FE-E516C6F07422Q36553255-88D44B90-25A9-416B-A2E5-2320946E61B9Q36702887-D377E1B0-3199-45F3-8FE4-B98465C9F596Q36731317-354649E9-6093-469C-815A-48F385B76588Q37616492-86CA96C3-333B-4B18-94F3-4B5FE9C940DDQ38152851-6936E514-85A3-46BA-88DC-278D2FE66F9EQ41298215-445E892C-25F3-4985-8694-1D72FC620B17Q42317402-32151638-4F62-4B63-8311-7208F8847B5EQ51701384-AAE08C83-2F1E-4EEA-8F8E-9F8175D05AD8Q55162750-58B8658F-72BC-4218-A8A1-08925D166D8D
P2860
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@ast
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@en
type
label
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@ast
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@en
prefLabel
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@ast
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@en
P2093
P2860
P1476
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.
@en
P2093
Connie J Rogers
Jeffrey Schlom
John W Greiner
Kenneth W Hance
P2860
P304
P356
10.1097/CJI.0B013E3181EB826D
P577
2010-09-01T00:00:00Z